Otofarma SpA (MIL:OTO) EV-to-EBIT: (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.76
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Otofarma SpA's Enterprise Value is €16.78 Mil. Otofarma SpA does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Otofarma SpA's EV-to-EBIT at this moment.

The historical rank and industry rank for Otofarma SpA's EV-to-EBIT or its related term are showing as below:

MIL:OTO' s EV-to-EBIT Range Over the Past 10 Years
Min: 0   Med: 0   Max: 8.67
Current: 8.67

During the past 2 years, the highest EV-to-EBIT of Otofarma SpA was 8.67. The lowest was 0.00. And the median was 0.00.

MIL:OTO's EV-to-EBIT is ranked better than
81.94% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 18.37 vs MIL:OTO: 8.67

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Otofarma SpA's Enterprise Value for the quarter that ended in Dec. 2024 was €0.00 Mil. Otofarma SpA does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate Otofarma SpA's Earnings Yield (Joel Greenblatt) % at this moment.

Otofarma SpA  (MIL:OTO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Otofarma SpA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=/0
= %

Otofarma SpA EV-to-EBIT Related Terms

Otofarma SpA EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA EV-to-EBIT Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
EV-to-EBIT
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
EV-to-EBIT 0.00 0.00

MIL:OTO vs ABT, SYK, MDT: EV-to-EBIT Comparison

For the Medical Devices subindustry, Otofarma SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Otofarma SpA EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Otofarma SpA's EV-to-EBIT falls into.


MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA EV-to-EBIT Calculation

Otofarma SpA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=16.784/
=

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.76
Price